191
Views
2
CrossRef citations to date
0
Altmetric
Hepatobiliary

Functional variants of eNOS and iNOS genes have no relationship to the portal hypertension in patients with liver cirrhosis

, , , , , , , & show all
Pages 592-601 | Received 17 Nov 2012, Accepted 01 Feb 2013, Published online: 04 Mar 2013

References

  • Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: A role for nitric oxide? Lancet 1991;337:776.
  • Martin P, Xu D, Niederberger M, Weigert A, Tsai P, St John J, Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol 1996;270:F494–9.
  • Bhathal P, Grossman H. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilatators. J Hepatol 1985;1:325–37.
  • Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, Endotelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996;110:534–48.
  • Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough. Hepatology 2002;35:478–91.
  • Gracia-Sancho J, Lavina B, Rodriguez-Vilarrupla A, García-Calderó H, Fernández M, Bosch J, Increased oxidative stress in cirrhotic rat livers: a potential mechanism contributing to reduced nitric oxide bioavailability. Hepatology 2008;47:1248–56.
  • Furchogott RF. Studies on endothelium-dependent vasodilatation and the endothelium-derived relaxing factor. Acta Physiol Scand 1990;139:257–70.
  • Fernández M, García-Pagán JC, Casadevall M, Bernadich C, Piera C, Whittle BJ, Evidences against a role for the inducible NO synthase in the hyperdynamic circulation of portal hypertensive rats. Gastroenterology 1995;108:1487–95.
  • Xu J, Cao H, Liu H, Wu ZY. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension. Hepatobiliary Pancreat Dis Int 2008;7:503–8.
  • Jeremy JY, Yim AP, Wan S, Angelini GD. Oxidative stress, nitric oxide, and vascular disease. J Card Surg 2002;17:324–7.
  • Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999;100:1515–20.
  • Hingorani AD. Endothelial nitric oxide synthese polymorphism and hypertension. Curr Hypertension Rep 2003;5:19–25.
  • Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998;31:1506–10.
  • Selmi C, Zuin M, Biondi ML, Invernizzi P, Battezzati PM, Bernini M, Genetic variants of endothelial nitric oxde synthase in patients with primary biliary cirrhosis: Association with disease severity. J Gastroenterol Hepatol 2003;18:1150–5.
  • Cheng YQ, Lin JS, Liao JZ, Liang KH, Xiong P. The association between polymorphism of endothelial nitric oxide synthase gene and cirrhotic portal hypertension. Zhonghua Yi Xue Za Zhi 2003;83:1116–21; in Chinese.
  • Cheng YQ, Lin JS, Wang WQ, Xiong P, Jiang XD. A study of the association of iNOS and eNOS gene polymorphism with portal hypertension in liver cirrhosis. Zhonghua Gan Zang Za Zhi 2005;13:366–9; in Chinese.
  • Bruha R, Petrtyl J. Importance of HVPG measurement in patients with liver cirrhosis. Gastroenterol Hepatol 2011;65:143–8.
  • Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 2004;39:280–2.
  • Jachymova M, Horky K, Bultas J, Kozich V, Jindra A, Peleska J, Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthese gene with Essentials hypertension resistant to conventional therapy. Biochem Biophys Res Commun 2001;284:426–30.
  • Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DEL. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996;2:41–5.
  • Ichihara S, Yamada Y, Fujimura T, Nakashima N, Yokota M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 1998;81:83–6.
  • Forte P, Kneale BJ, Milne E, Chowienczyk PJ, Johnston A, Benjamin N, Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension 1998;32:730–4.
  • Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 2002;23:665–86.
  • Page A, Reich H, Zhou J, Lai V, Cattran DC, Scholey W, Endothelial nitric oxide synthase gene/gender interactions and the renal hemodynamic response to angiotensin II. J Am Soc Nephrol 2005;16:3053–60.
  • Wiest R, Cadelina G, Milstien S, McCuskey RS, Garcia-Tsao G, Groszmann RJ. Bacterial translocation up-regulates GTP-cyclohydrolase I in mesenteric vasculature of cirrhotic rats. Hepatology 2003;38:1508–15.
  • Cahill PA, Redmond EM, Sitzmann JV. Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther 2001;89:273–93.
  • Giron-Gonzales JA, Martinez-Sierra C, Rodriguez-Ramos C, Macias MA, Rendon P, Diaz F, Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int 2004;24:437–45.
  • Lee FY, Lu RH, Tsai YT, Lin HC, Hou MC, Li CP, Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-α, and hyperdynamic circulation. Scand J Gastroenterol 1996;31:500–5.
  • Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G, Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264–74.
  • Genesca J, Gonzalez A, Segura R, Catalan R, Marti R, Varela E, Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol 1999;94:169–77.
  • Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993;11:767–804.
  • Yamaguchi M, Tokushige K, Haruta I, Yamauchi K, Hayashi N. Analysis of adhesion molecules in patients with idiopathic portal hypertension. J Gastroenterol Hepatol 1999;14:364–9.
  • Girón-González JA, Martínez-Sierra C, Rodriguez-Ramos C, Rendón P, Macías MA, Fernández-Gutiérrez C, Adhesion molecules as a prognostic marker of liver cirrhosis. Scand J Gastroenterol 2005;40:217–24.
  • La Mura V, Reverter JC, Flores-Arroyo A, Raffa S, Reverter E, Seijo S, Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension. Gut 2011;60:1133–8.
  • Cervello M, Virruso L, Lipani G, Giannitrapani L, Soresi M, Carroccio A, Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. J Cancer Res Clin Oncol 2000;126:345–51.
  • Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989;243:1160–5.
  • Volpes R, Van den Oord JJ, Desmet VJ. Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology 1992;15:269–75.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.